SEC filing details
Document Details
Form
Filing Date
May 26, 2026
Document Date
May 15, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Nektar Therapeutics
Issuer
NEKTAR THERAPEUTICS
Filer
Rubinstein Linda M